Barrington Research Reiterates Outperform on ModivCare, Lowers Price Target to $58
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst Michael Petusky has reiterated an 'Outperform' rating on ModivCare (NASDAQ:MODV), but lowered the price target from $92 to $58.
August 07, 2023 | 4:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ModivCare's price target has been lowered from $92 to $58 by Barrington Research, although the 'Outperform' rating has been maintained.
The lowering of the price target by Barrington Research indicates a potential decrease in ModivCare's stock price in the short term. However, the 'Outperform' rating suggests that the company is still expected to perform well relative to its peers.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100